$PUBC
PureBase Corp Stock $pubc

$pubc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224014655 Filed on April 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$105.7K	$0.00	$52.26K
YoY Change	59.28%	-100.0%
Cost Of Revenue	$33.08K	$0.00	$22.46K
YoY Change	24.31%	-100.0%	591.08%
Gross Profit	$72.65K	$0.00	$29.80K
YoY Change	82.67%	-100.0%	-1016.92%
Gross Profit Margin	68.72%		57.03%
Selling, General & Admin	$388.2K	$461.8K	$5.887M
YoY Change	-83.28%	-92.16%	-47.44%
% of Gross Profit	534.36%		19754.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00	$0.00
YoY Change
% of Gross Profit	0.0%		0.0%
Operating Expenses	$392.4K	$461.8K	$5.909M
YoY Change	-83.1%	-92.19%	-47.24%
Operating Profit	-$319.7K	-$461.8K	-$5.857M
YoY Change	-85.99%	-92.12%	-47.72%
Interest Expense	-$18.75K	-$29.22K	$9.123K
YoY Change	-251.2%	-420.29%	-143.65%
% of Operating Profit
Other Income/Expense, Net	-$18.75K	$0.00	$26.28K
YoY Change	-107.14%	-100.0%	1207.36%
Pretax Income	-$338.5K	-$491.0K	-$5.831M
YoY Change	-83.24%	-91.58%	-48.04%
Income Tax	$2.400K
% Of Pretax Income
Net Earnings	-$340.9K	-$491.0K	-$5.831M
YoY Change	-83.12%	-91.58%	-48.04%
Net Earnings / Revenue	-322.44%		-11158.14%
Basic Earnings Per Share	$0.00	$0.00	-$0.03
Diluted Earnings Per Share	$0.00	$0.00	-$0.03
COMMON SHARES
Basic Shares Outstanding	240.1M shares	239.7M shares	230.5M shares
Diluted Shares Outstanding	246.9M shares	233.7M shares	230.7M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.94K	$5.760K	$21.42K
YoY Change	97.59%	-73.11%	98.89%
Cash & Equivalents	$45.94K	$5.760K	$21.42K
Short-Term Investments
Other Short-Term Assets	$32.68K	$52.54K	$2.960K
YoY Change	2669.49%	1675.0%	-77.34%
Inventory
Prepaid Expenses
Receivables	$50.03K		$53.88K
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$128.7K	$58.30K	$78.26K
YoY Change	41.68%	-25.5%	202.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$750.7K	$750.7K	$620.0K
YoY Change	21.08%	21.08%	-1.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$750.7K	$750.7K	$689.6K
YoY Change	10.45%	8.86%	9.23%
TOTAL ASSETS
Total Short-Term Assets	$128.7K	$58.30K	$78.26K
Total Long-Term Assets	$750.7K	$750.7K	$689.6K
Total Assets	$879.4K	$809.0K	$767.9K
YoY Change	14.13%	5.35%	16.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.63K	$190.1K	$145.3K
YoY Change	-80.21%	30.78%	-23.82%
Accrued Expenses	$103.1K	$126.5K	$39.37K
YoY Change	158.64%	221.26%	234.21%
Deferred Revenue
YoY Change
Short-Term Debt	$443.4K	$927.9K	$18.72K
YoY Change	3131.41%	4856.46%	-77.64%
Long-Term Debt Due	$31.00K	$25.00K	$42.00K
YoY Change	158.33%	-40.48%	-95.8%
Total Short-Term Liabilities	$846.1K	$1.784M	$736.1K
YoY Change	76.96%	142.42%	-70.97%
LONG-TERM LIABILITIES
Long-Term Debt	$412.0K	$103.0K	$919.2K
YoY Change	-69.06%	-88.79%	58.55%
Other Long-Term Liabilities	$6.730K		$30.85K
YoY Change	-67.49%
Total Long-Term Liabilities	$418.7K	$103.0K	$950.1K
YoY Change	-69.04%	-89.16%	63.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$846.1K	$1.784M	$736.1K
Total Long-Term Liabilities	$418.7K	$103.0K	$950.1K
Total Liabilities	$1.265M	$1.887M	$1.686M
YoY Change	-30.91%	11.94%	-45.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.56M	-$63.22M	-$59.47M
YoY Change	3.36%	6.3%
Common Stock	$250.3K	$240.0K	$160.1K
YoY Change	56.12%	49.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$385.5K	-$1.078M	-$918.2K
YoY Change
Total Liabilities & Shareholders Equity	$879.4K	$809.0K	$767.9K
YoY Change	14.13%	5.35%	16.85%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$340.9K	-$491.0K	-$5.831M
YoY Change	-83.12%	-91.58%	-48.04%
Depreciation, Depletion And Amortization	$0.00	$0.00	$0.00
YoY Change
Cash From Operating Activities	-$784.3K	-$675.2K	-$287.6K
YoY Change	96.98%	134.75%	20.08%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	824.5K	675.4K	$290.0K
YoY Change	106.13%	132.9%	145.76%
NET CHANGE
Cash From Operating Activities	-784.3K	-675.2K	-$287.6K
Cash From Investing Activities		0.000
Cash From Financing Activities	824.5K	675.4K	$290.0K
Net Change In Cash	40.18K	190.0	$2.368K
YoY Change	2107.69%	-91.98%
FREE CASH FLOW
Cash From Operating Activities	-$784.3K	-$675.2K	-$287.6K
Capital Expenditures		$0.00
Free Cash Flow		-$675.2K	-$287.6K
YoY Change		134.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q4	PUBC	Right Of Use Asset Current RightOfUseAssetCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2024Q1	us-gaap	Gross Profit GrossProfit		usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	PUBC	Stock Issued For Services StockIssuedForServices		usd
CY2024Q1	PUBC	Gain Loss On Debt Forgiveness GainLossOnDebtForgiveness		usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2023Q1	PUBC	Increase Decrease In Settlement Liability IncreaseDecreaseInSettlementLiability		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit		usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	PUBC	Vendors Paid For On Behalf Of Company VendorsPaidForOnBehalfOfCompany		usd
CY2024Q1	PUBC	Due To Affiliates Exchanged For Convertible Debt DueToAffiliatesExchangedForConvertibleDebt		usd
CY2023Q1	PUBC	Convertible Debt And Accrued Interest Converted To Common Stock Related Party ConvertibleDebtAndAccruedInterestConvertedToCommonStockRelatedParty		usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome		usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome		usd
CY2024Q1	PUBC	Accrued Consultants AccruedConsultants		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-02-29
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-55517
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	PUREBASE CORPORATION
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-2060863
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8631 State Highway 124
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ione
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95640
CY2024Q1	dei	City Area Code CityAreaCode	(209)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	274-9143
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	240057595	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5572	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22692	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15434	usd
CY2024Q1	PUBC	Right Of Use Asset Current RightOfUseAssetCurrent	29850	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	58302	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	21006	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	29793	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	453565	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750716	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750716	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39799	usd
CY2024Q1	us-gaap	Assets Assets	809018	usd
CY2023Q4	us-gaap	Assets Assets	811521	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	285720	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	481024	usd
CY2024Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	515000	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	618000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	919135	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	346735	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	30851	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	40880	usd
CY2024Q1	PUBC	Notes Payable Excluding Convertible Notes Payable Current NotesPayableExcludingConvertibleNotesPayableCurrent	8716	usd
CY2023Q4	PUBC	Notes Payable Excluding Convertible Notes Payable Current NotesPayableExcludingConvertibleNotesPayableCurrent	8716	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	25000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	19000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1784422	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1514355	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	103000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1525676	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1887422	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3040031	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	520000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	520000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240040928	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240040928	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	230863005	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	230863005	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	240041	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	230863	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61903505	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60271605	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63221950	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62730978	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1078404	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2228510	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	809018	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	811521	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52256	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22463	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	401857	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8191	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5485013	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	461756	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5886870	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-461756	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5857077	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	35401	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	29216	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9123	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29216	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	26278	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-490972	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5830799	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	233712013	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	233712013	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230749672	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	230749672	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-572460	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5485013	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-918246	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2228510	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2228510	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4191	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1612887	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-490972	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1078404	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1078404	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-490972	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5830799	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8191	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5485013	usd
CY2024Q1	PUBC	Stock Issued For Services StockIssuedForServices	24000	usd
CY2024Q1	us-gaap	Officers Compensation OfficersCompensation	6000	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	6000	usd
CY2023Q1	PUBC	Gain Loss On Debt Forgiveness GainLossOnDebtForgiveness	35401	usd
CY2024Q1	PUBC	Right Of Use Asset And Liability Net RightOfUseAssetAndLiabilityNet	80	usd
CY2023Q1	PUBC	Right Of Use Asset And Liability Net RightOfUseAssetAndLiabilityNet	-412	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	53880	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11258	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1774	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-108093	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	139249	usd
CY2024Q1	PUBC	Increase Decrease In Settlement Liability IncreaseDecreaseInSettlementLiability	103000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-675212	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-287632	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	103000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	300000	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	572400	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	675400	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	290000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	188	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2368	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5572	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19055	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5760	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21423	usd
CY2023Q1	PUBC	Vendors Paid For On Behalf Of Company VendorsPaidForOnBehalfOfCompany	8320	usd
CY2023Q1	PUBC	Due To Affiliates Exchanged For Convertible Debt DueToAffiliatesExchangedForConvertibleDebt	300000	usd
CY2024Q1	PUBC	Convertible Debt And Accrued Interest Converted To Common Stock Related Party ConvertibleDebtAndAccruedInterestConvertedToCommonStockRelatedParty	1612887	usd
CY2024Q1	PUBC	Director Compensation Accrued As Convertible Debt Converted To Common Stock DirectorCompensationAccruedAsConvertibleDebtConvertedToCommonStock	6000	usd
CY2023Q1	PUBC	Director Compensation Accrued As Convertible Debt Converted To Common Stock DirectorCompensationAccruedAsConvertibleDebtConvertedToCommonStock	6000	usd
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2010-03-02
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63221950	usd
CY2024Q1	PUBC	Working Capital Deficit WorkingCapitalDeficit	-1726120	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-490972	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-675212	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zTF7V1cQvDX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zvMiebvrxvJ2">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and equity-based transactions at the date of the financial statements and the revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations may be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the condensed consolidated financial statements. Significant estimates include the useful lives of property and equipment, deferred tax asset and valuation allowance, and assumptions used in the Black-Scholes valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52256	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q1	PUBC	Property Equipment Excluding Plant PropertyEquipmentExcludingPlant	620000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	67164	usd
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6500	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	0	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	139184434	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	131441465	shares
CY2024Q1	us-gaap	Area Of Land AreaOfLand	700	sqft
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	3500	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	817880	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	817880	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67164	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	67164	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750716	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	750716	usd
CY2024Q1	us-gaap	Depreciation Depreciation	0	usd
CY2023Q1	us-gaap	Depreciation Depreciation	0	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	10500	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	10500	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	10500	usd
CY2024Q1	PUBC	Operating Lease Operating Cash Flows Liability Reduction OperatingLeaseOperatingCashFlowsLiabilityReduction	10029	usd
CY2024Q1	PUBC	Right Of Use Asset Current RightOfUseAssetCurrent	29850	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	30851	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	10500	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	10500	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	10500	usd
CY2023Q1	PUBC	Operating Lease Operating Cash Flows Liability Reduction OperatingLeaseOperatingCashFlowsLiabilityReduction	9538	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69649	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39372	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30852	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	31500	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	649	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	30851	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	190091	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	314502	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	61019	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	120011	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	34610	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39080	usd
CY2023Q4	PUBC	Accrued Consultants AccruedConsultants	7431	usd
CY2024Q1	PUBC	Accounts Payable And Accrued Expenses AccountsPayableAndAccruedExpenses	285720	usd
CY2023Q4	PUBC	Accounts Payable And Accrued Expenses AccountsPayableAndAccruedExpenses	481024	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	128688187	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	128688187	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	129438187	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.09
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	129638187	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	129638187	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y5M4D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.53
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	129438187	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	675400	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	16667	shares
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd

Files In Submission

Name	View Source	Status
0001493152-24-014655-index-headers.html	Edgar Link	pending
0001493152-24-014655-index.html	Edgar Link	pending
0001493152-24-014655.txt	Edgar Link	pending
0001493152-24-014655-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pubc-20240229.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pubc-20240229_cal.xml	Edgar Link	unprocessable
pubc-20240229_def.xml	Edgar Link	unprocessable
pubc-20240229_lab.xml	Edgar Link	unprocessable
pubc-20240229_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PUBC
PureBase Corp Stock $pubc

2024 Q2 Form 10-Q Financial Statement

#000149315224014655 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PUBC PureBase Corp Stock $pubc

2024 Q2 Form 10-Q Financial Statement

#000149315224014655 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PUBC
PureBase Corp Stock $pubc